May 10th 2024
WGc-043 is the first and only vaccine approved for this use.
Reducing Barriers Associated With Pneumococcal Vaccine Uptake
1.5 Credits / Immunization, Infectious Diseases
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Vaccine-Preventable Diseases: Strategies for Addressing Vaccine Hesitancy and Improving Vaccine Confidence
1.0 Credit / Immunization
View More
The Expanding Landscape of Vaccinations for the Prevention of Pneumococcal Disease: The Role of the Pharmacist as Patient Educator and Vaccinator
1.0 Credit / Pneumococcal Disease
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults
2.0 Credits / Infectious Diseases, Respiratory, Immunization
View More
Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccine Landscape
1.25 Credits / Immunization, Infectious Disease
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacist Credit)
2.0 Credits / Immunization
View More
Identifying Candidates for Meningococcal Vaccines (Pharmacy Technician Credit)
2.0 Credits / Immunization
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
The Pharmacist’s Impact on Shingles Prevention Through Vaccination: Recommendations, Uptake, and Improved Outcomes
1.5 Credits / Immunization
View More
ASHP Urges Biden to Use Federal Resources, Expand Workforce for COVID-19 Vaccinations
January 20th 2021In a letter to President Joe Biden, ASHP and more than 50 signers called for use of federal resources and expansion of the vaccinator workforce to confront the slow ramping up of COVID-19 vaccinations.